BXP
BXP, Inc.70.70
-0.92-1.28%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
12.51BP/E (TTM)
-Basic EPS (TTM)
-1.28Dividend Yield
0.05%Recent Filings
8-K
BXP Q3 revenue up, FFO beats
BXP reported Q3 2025 results with revenue up 1.4% to $871.5 million, but net loss of $121.7 million due to $214 million non-cash impairments on joint ventures and pending sales. FFO rose to $1.74 per share, beating guidance amid strong leasing of 1.5 million square feet. Portfolio occupancy dipped to 86.0%, yet CBD assets held at 89.3% occupied. Impairments signal asset repositioning risks.
8-K
BXP issues $1B exchangeable notes
BXP's operating partnership completed a $1.0 billion issuance of 2.00% exchangeable senior notes due 2030 on September 29, 2025, upsized from $850 million with full exercise of the $150 million option. The notes, exchangeable into BXP common stock at an initial rate of 10.8180 shares per $1,000 principal (about $92.44 per share), carry semi-annual interest starting April 2026 and are redeemable after October 2028 under certain conditions. Proceeds will partly fund capped call transactions to curb dilution and repay $1.0 billion in 3.65% notes maturing February 2026, with the rest from cash or credit facility. Hedging by counterparties may sway stock prices.
10-Q
Q2 FY2025 results
BXP's Q2 revenue climbed 2.2% y/y to $868.5M, driven by 1.9% higher lease income from stronger occupancy in premier assets, while total NOI edged up 1.1% to $514.1M amid controlled expenses. Operating income rose 2.2% y/y to $256.2M (derived), but net income dipped slightly q/q; diluted EPS held steady at $0.56, reconciling to 158.8M weighted shares with no anti-dilution flagged. Key drivers included a $18.4M gain from selling 17 Hartwell Avenue land into a JV for $21.8M cash (20% retained interest), boosting liquidity alongside $447M cash and $1.0B revolver availability, though debt stood at $15.8B with covenants met. Free cash flow wasn't disclosed in the 10-Q. Yet competition from remote work lingers.
8-K
BXP beats Q2 FFO guidance
BXP reported Q2 2025 results with revenue up 2.1% to $868.5 million and FFO of $1.71 per diluted share, beating guidance amid resilient leasing. Executed 1.1 million square feet of leases, including key deals at 725 12th Street and Reston Next, while advancing 343 Madison Avenue development in NYC, now 30% pre-leased. Occupancy dipped to 86.4% due to a known expiration, yet CBD assets held strong at 89.9%. Raised full-year FFO guidance to $6.84-$6.92, signaling steady progress. Risks linger from economic volatility.
8-K
BXP annual meeting outcomes
BXP, Inc. held its 2025 annual stockholder meeting on May 20, electing all 11 director nominees, including Bruce W. Duncan and Owen D. Thomas, with votes ranging from 112 million to 138 million for amid 5.5 million broker non-votes. Stockholders approved executive compensation on an advisory basis (123.5 million for) and ratified PwC as auditors (134.5 million for). Continuity intact. No controversies noted.
ARE
Alexandria Real Estate Equities
46.97-0.44
BDN
Brandywine Realty Trust
3.08-0.02
BRX
Brixmor Property Group Inc.
25.57-0.50
EXR
Extra Space Storage Inc
130.70-2.60
FSP
Franklin Street Properties Corp
0.98+0.01
LXP
LXP Industrial Trust
50.00+0.02
O
Realty Income Corporation
57.44-0.64
PDM
Piedmont Realty Trust, Inc.
8.77+0.13
REXR
Rexford Industrial Realty, Inc.
40.72-0.41
WPC
W. P. Carey Inc. REIT
64.97-0.78